Curis (CRIS) Assets Average (2011 - 2026)
Curis (CRIS) reported Assets Average of $24.8 million for Q1 2026, down 38.39% on a YoY basis from $40.3 million in Q1 2025, and up 4.3% quarter-over-quarter from $23.8 million in Q4 2025.
Curis (CRIS) Assets Average (2011 - 2026) Analysis & Trends
Curis has reported Assets Average for 16 years, with the latest figure at $24.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 38.39% year-over-year to $24.8 million; the trailing twelve-month figure through Mar 2026 stood at $24.8 million (down 38.39% YoY), and the FY2025 full-year result was $30.6 million, down 48.35% from the prior year.
- Assets Average for Q1 2026 stood at $24.8 million, up from $23.8 million in the prior quarter.
- The five-year high for Assets Average was $151.5 million in Q1 2022, with the low at $23.8 million in Q4 2025.
- Historically, Assets Average has averaged $73.9 million across 5 years, with a median of $69.7 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average fell 23.27% — and 2024, when it slumped 49.93%.
- Curis' Assets Average stood at $115.9 million in 2022, then fell by 27.81% to $83.6 million in 2023, then sank by 49.93% to $41.9 million in 2024, then slumped by 43.15% to $23.8 million in 2025, then climbed by 4.3% to $24.8 million in 2026.
- The last three Assets Average figures came in at $24.8 million (Q1 2026), $23.8 million (Q4 2025), and $28.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 660.38 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 24.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.83 Mn |
| Dec 31, 2025 | 23.80 Mn |
| Sep 30, 2025 | 28.44 Mn |
| Jun 30, 2025 | 34.28 Mn |
| Mar 31, 2025 | 40.30 Mn |
| Dec 31, 2024 | 41.87 Mn |
| Sep 30, 2024 | 46.44 Mn |
| Jun 30, 2024 | 56.22 Mn |
| Mar 31, 2024 | 69.65 Mn |
| Dec 31, 2023 | 83.63 Mn |
| Sep 30, 2023 | 87.14 Mn |
| Jun 30, 2023 | 89.43 Mn |
| Mar 31, 2023 | 101.70 Mn |
| Dec 31, 2022 | 115.85 Mn |
| Sep 30, 2022 | 125.84 Mn |
| Jun 30, 2022 | 134.79 Mn |
| Mar 31, 2022 | 151.52 Mn |
| Dec 31, 2021 | 167.19 Mn |
| Sep 30, 2021 | 176.64 Mn |
| Jun 30, 2021 | 185.89 Mn |